NRP1 and hematologic disorder: These results indicated that NRP‐1/CD304 had no obvious value in flow detection and follow‐up study in the above hematological diseases, and it was not necessary to include NRP‐1/CD304 in the panel design of immunophenotyping and MRD detection protocols.